COX-2 expression also correlates with poor prognostic indicators, such as increased tumor size, axillary node and distant metastasis, tumor grade, high-proliferation rates, receptor-negative disease, and HER2 amplification [94, 95]. This evidence concerns the gene ERBB2 and neoplasm.